Nutrition and Cancer: Myths and Legends. When someone is diagnosed with cancer, the search is on for information. People look to something they can control, like food. There are often misconceptions out there regarding food which can be confusing. This talk focuses on some of these “questionable” foods/nutrients and help you understand the real story. Speaker: Erika Connor, RD, CSO, Dietitian; Cancer Supportive Care Program, Stanford Cancer Institute.
Marshall Edwards explains how a new investigational drug called phenoxodiol is restoring sensitivity to the cancer cells of patients that have become resistant to standard chemotherapy drugs. Phenoxodiol has not yet been approved by the regulatory agencies, such as the US Food and Drug Administration (FDA), for commercial distribution. Phenoxodiol is a pill taken by mouth.
From www.beetmedicine.tv Breast and ovarian cancers are among the few diseases where a blood test can demonstrate whether a woman has a mutation of genes BRCA1 and 2 which are specific and predict for hereditary cancer. Shivani Nazareth, a genetics counselor, describes who should be tested, what can be learned from the blood test and why it useful in making decisions about treatments whether it is positive or negative. — Peter Pressman, MD About our interviewee: Shivani Nazareth, MS, is a Certified Genetic Counselor at the Weill Cornell Medical College.
Screening for Ovarian Cancer: Any Survival Benefit? Dr. Sandra Fryhofer, expert commentator for Medscape, discusses screening for ovarian cancer using the CA-125 test in light of a 13-year study of its impact on survival. View more Fryhofer videos on Medscape: www.medscape.com